1351219-37-8

Basic information

• Product Name: allyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl-(1->6)-4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside
• CAS NO: 1351219-37-8
• Molecular Weight: 939.023
• Mol File: 1351219-37-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: allyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl-(1->6)-4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: allyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl-(1->6)-4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside(1351219-37-8)
• EPA Substance Registry System: allyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl-(1->6)-4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside(1351219-37-8)

Safety Data

• Hazardous Substances Data: 1351219-37-8(Hazardous Substances Data)

Upstream product

• 127514-28-7 Allyl 2-O-benzoyl-4,6-O-benzylidene-α-D-glucopyranoside 
• 152871-96-0 phenyl 1-deoxy-2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
• 123-76-2 levulinic acid 
• 1351219-19-6 allyl 2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside 
• 1351219-36-7 allyl 2-O-benzoyl-4,6-O-benzylidene-3-O-levulinoyl-α-D-glucopyranoside 
• 1351219-20-9 allyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl-(1->6)-2-O-benzoyl-3-O-levulinoyl-α-D-glucopyranoside 
• 108-24-7 acetic anhydride 

Relevant articles and documents

Synthesis of laminarin fragments and evaluation of a β-(1,3) glucan hexasaccaride-CRM197 conjugate as vaccine candidate against Candida albicans

Laminarin-CRM197 glycoconjugates were previously demonstrated to be immunogenic and confer protection against Candida albicans in mice. Laminarin consists of β-(1,3) glucan repeating units, with sporadic β-(1,6) branches. A set of short glucans was used to study the effect of the β-(1,6) branch on the antigenicity of linear β-(1,3) glucans. A linear β-(1,3) glucan hexasaccharide was selected as the best fragment able to inhibit the binding between laminarin and antilaminarin antibodies. The hexamer was then conjugated to CRM197 and induced, in mice, significant titers of specific antilaminarin antibodies comparable with those raised by the Lam-CRM197 conjugate. Copyright Taylor & Francis Group, LLC.